Gene Surgery LLC

Россия

AntioncoRAN-M

Project description

AntioncoRAN-M is a Russian gene therapy drug for treating solid tumors, combining a cancer cell-killing gene and an immune activation gene. It has successfully completed Phase 1 clinical trials proving safety and shows promise against multiple cancer types, targeting a large oncology market with high unmet medical needs.

Аmount of required investment

On request

Estimated payback period

On request

Get project details

AntioncoRAN-M

invest@rusthaibusiness.com